Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lung-benefiting Moxibustion for Asthma Exacerbations
NCT06777472Not yet recruiting
- Start
- Jul 2025
- Primary completion
- Sep 2026
01
Overview
Randomised, open-label trial in asthma (2 arms). Primary endpoint: Annual number of flare-up of asthma at 1 year. Planned start Jul 2025; status: not yet recruiting.
02
Conditions
asthma
Beyond the preview
Go deeper on NCT06777472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06777472.